A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC
Clinical trial NCT06775275 · RECRUITING
Trial details
- NCT number
- NCT06775275
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-24
- Primary completion
- 2025-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.